-
Why Big Tech’s move into medicine is a mistake
Opinion The big tech companies have long wanted a slice of the medical action, and now they are moving in. They are making a big mistake and will fae a huge backlash, says Matthew Lynn.
Opinion -
Why UK companies should lean in and poach Sheryl Sandberg
Opinion Sheryl Sandberg has quit Facebook. Now’s the time for corporate Britain to move in and poach her says Matthew Lynn.
Opinion -
What to buy as the tech-stock bull market crashes
Cover Story The decade-long bull market in tech stocks has come to a rapid halt. Investors need to distinguish solid stocks from speculative ones rather than just buying the dip, says Matthew Partridge
Cover Story -
Tech stock crash – dotcom bust 2.0 is upon us
Opinion It’s carnage in the tech sector as the market crashes. But that spells opportunity for canny investors, says Matthew Lynn
Opinion -
Fang tech stocks: Meta and Netflix lose their bite
Analysis Investors treated the Fang tech stocks as almost identical, but two of them are much weaker than the rest, says Philip Pilkington.
Analysis -
Tech stock crash: Alphabet and Microsoft look like gems in the rubble
Analysis Tech stocks have fallen hard this, with the Nasdaq index down 22% since November. But both Alphabet and Microsoft are still both worth a look, says Rupert Hargreaves.
Analysis -
Nine new ETFs to consider
Analysis New launches of traditional funds are in short supply, but the ETF market keeps growing, says David Stevenson.
Analysis -
Why the EU should fear an exodus of Big Tech companies
Opinion Politicians are making the EU a hostile environment for Big Tech. It would be wise to tread more carefully, says Matthew Lynn.
Opinion -
Cryptocurrency roundup: Facebook U-turns on crypto-ad ban
News As Facebook makes a U-turn on accepting cryptocurrency ads, Saloni Sardana casts her eye over the stories that have caught our eye in the last seven days.
News
